# Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia

> **NCT02192450** · PHASE4 · COMPLETED · sponsor: **Nordsjaellands Hospital** · enrollment: 149 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus
- Nocturnal Hypoglycemia
- Recurrent Severe Hypoglycaemia

## Interventions

- **DRUG:** Insulin aspart/glargine
- **DRUG:** Insulin aspart/degludec

## Key facts

- **NCT ID:** NCT02192450
- **Lead sponsor:** Nordsjaellands Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2019-02-28
- **Final completion:** 2019-02-28
- **Target enrollment:** 149 (ACTUAL)
- **Last updated:** 2019-06-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02192450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02192450, "Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02192450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*